City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Ryotaro Nakamura, MD  
Search results:  5  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-5 Trials Jump to page:

COH Protocol Number: 12261

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Institutional

Title:  Single Patient Compassionate Use of De-Immunized DI-Leu16-IL2 Immunocytokine in a Patient with Primary Cutaneous Large B-Cell Non-Hodgkin's Lymphoma

COH Protocol Number: 12022 ClinicalTrials.gov Number: NCT01588015

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Institutional

Title:  A Phase I Trial To Evaluate Safety and Immunogenicity of a Cytomegalovirus Peptide Vaccine Co-Injected with PF-03512676 Adjuvant in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

COH Protocol Number: 11274 ClinicalTrials.gov Number: NCT01295710

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Industrial

Title:  A Randomized, Prospective, Double Blind, Placebo-Controlled, Phase 3 Study of US-ATG-F Prophylaxis as a Supplement to Standard of Care Prophylaxis to Prevent Moderate to Severe Chronic GVHD in Adult Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome Patients after Allogeneic Stem Cell Transplantation from Unrelated Donors

COH Protocol Number: 05201 ClinicalTrials.gov Number: NCT00326417

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Cooperative Group

Title:  BMT CTN 0301: Fludarabine-based Conditioning for Allogeneic Marrow Transplantation From HLA-compatible Unrelated Donors in Severe Aplastic Anemia

COH Protocol Number: 03131 ClinicalTrials.gov Number: NCT00720135

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: NCI Approved External Peer Review

Title:  A Phase I Study of De-Immunized DI-Leu16-IL2 Immunocytokine in Patients with B-Cell Non-Hodgkin Lymphoma

 
Results per page: 25 50 100 All 1-5 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.